To test whether SGK1 plays a role in obesity-induced AF, we employed a previously described transgenic mouse model that overexpresses a dominant-negative form of SGK1 in cardiomyocytes (SGK1 dominant negative, DN) (30). Here, SGK1 is linked to obesity disorder.